EpiPen's Swollen Price May Trigger Patient Assistance Program Probes
Executive Summary
Mylan's $600 price tag for its emergency anaphylaxis treatment EpiPen (epinephrine) could spur more than probes into the company's pricing practices. It could turn into a wider investigation into industry's use of patient assistance programs.
You may also be interested in...
Teva Launches Generic EpiPen At Same Price As Mylan's Generic
Teva's epinephrine will be the first alternative to branded and authorized generics made by Mylan, but the wholesale acquisition cost of $300 for a two-pack won't be lower.
Teva Launches Generic EpiPen At Same Price As Mylan's Generic
Teva's epinephrine will be the first alternative to branded and authorized generics made by Mylan, but the wholesale acquisition cost of $300 for a two-pack won't be lower.
Mylan CEO Heather Bresch On How Mylan Is Different Than Teva
CEO Heather Bresch talked to Scrip about how she will navigate the company through what has become a rough period for the US generic drug market and validation on complex generics and biosimilars.